Evidence map›Paper›PMID 36396627›Full record

ArticleCell death discovery2022

METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m

Haiyun Xie, Mingchao Wang, Haifeng Yu, Huan Wang, Lifeng Ding, Ruyue Wang, Wenqin Luo, Zeyi Lu, Qiming Zheng, Liangliang Ren and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Adenosine 5'-Carboxamide-Based Inhibitors of METTL1.ACS medicinal chemistry letters · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Deciphering the secret codes in NClinical and translational medicine · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. The role of m5C, m1A and m7G modifications in tumors of urinary system.Frontiers in cell and developmental biology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Pan-Cancer Analysis Links Altered RNA mCancer reports (Hoboken, N.J.) · 2024
    Article
  16. Article
  17. Article
  18. m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Haiyun Xie *Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Mingchao Wang *Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Haifeng Yu *Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Huan WangDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.ORCID http://orcid.org/0000-0001-9409-5984
Lifeng DingDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Ruyue WangDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Wenqin LuoDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Zeyi LuDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Qiming ZhengDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Liangliang RenDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Zhenwei ZhouDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China.
Wenjing SuLife Sciences Institute of Zhejiang University, 866 Yuhangtang Road, 310058, Hangzhou, Zhejiang, PR China.
Liqun XiaDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China. xialiqun@zju.edu.cn.ORCID http://orcid.org/0000-0001-5040-4992
Gonghui LiDepartment of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, Zhejiang, PR China. 3193119@zju.edu.cn.ORCID http://orcid.org/0000-0001-9845-7241
Sir Run Run Shaw Hospital · CNZhejiang University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81870484
6 · The paper itself

Abstract

7-methylguanosine (m

Identifiers

PMID36396627
PMCPMC9672058
OpenAlexW4309473726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.